Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 402

1.

Genetic variation in brain-derived neurotrophic factor val66met allele is associated with altered serotonin-1A receptor binding in human brain.

Lan MJ, Ogden RT, Huang YY, Oquendo MA, Sullivan GM, Miller J, Milak M, Mann JJ, Parsey RV.

Neuroimage. 2014 Jul 1;94:33-9. doi: 10.1016/j.neuroimage.2014.02.027. Epub 2014 Mar 5.

2.

Exploring the impact of BDNF Val66Met genotype on serotonin transporter and serotonin-1A receptor binding.

Kraus C, Baldinger P, Rami-Mark C, Gryglewski G, Kranz GS, Haeusler D, Hahn A, Wadsak W, Mitterhauser M, Rujescu D, Kasper S, Lanzenberger R.

PLoS One. 2014 Sep 4;9(9):e106810. doi: 10.1371/journal.pone.0106810. eCollection 2014. Erratum in: PLoS One. 2014;9(11):e113173. Gryglewsky, Gregor [corrected to Gryglewski, Gregor].

3.

Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality.

Miller JM, Brennan KG, Ogden TR, Oquendo MA, Sullivan GM, Mann JJ, Parsey RV.

Neuropsychopharmacology. 2009 Sep;34(10):2275-84. doi: 10.1038/npp.2009.54. Epub 2009 May 20.

4.

Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study.

Parsey RV, Oquendo MA, Ogden RT, Olvet DM, Simpson N, Huang YY, Van Heertum RL, Arango V, Mann JJ.

Biol Psychiatry. 2006 Jan 15;59(2):106-13. Epub 2005 Sep 9.

PMID:
16154547
5.

Serotonin-1A receptor imaging in recurrent depression: replication and literature review.

Drevets WC, Thase ME, Moses-Kolko EL, Price J, Frank E, Kupfer DJ, Mathis C.

Nucl Med Biol. 2007 Oct;34(7):865-77. Review.

6.

Reduced fractional anisotropy in the uncinate fasciculus in patients with major depression carrying the met-allele of the Val66Met brain-derived neurotrophic factor genotype.

Carballedo A, Amico F, Ugwu I, Fagan AJ, Fahey C, Morris D, Meaney JF, Leemans A, Frodl T.

Am J Med Genet B Neuropsychiatr Genet. 2012 Jul;159B(5):537-48. doi: 10.1002/ajmg.b.32060. Epub 2012 May 14.

PMID:
22585743
7.

Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression.

Sullivan GM, Ogden RT, Oquendo MA, Kumar JS, Simpson N, Huang YY, Mann JJ, Parsey RV.

Biol Psychiatry. 2009 Aug 1;66(3):223-30. doi: 10.1016/j.biopsych.2009.01.028. Epub 2009 Mar 17.

8.

Association between triallelic polymorphism of the serotonin transporter and [18F]MPPF binding potential at 5-HT1A receptors in healthy subjects.

Lothe A, Boni C, Costes N, Gorwood P, Bouvard S, Le Bars D, Lavenne F, Ryvlin P.

Neuroimage. 2009 Aug 15;47(2):482-92. doi: 10.1016/j.neuroimage.2009.04.067. Epub 2009 May 3.

PMID:
19409499
9.

Association of functional polymorphisms from brain-derived neurotrophic factor and serotonin-related genes with depressive symptoms after a medical stressor in older adults.

Rawson KS, Dixon D, Nowotny P, Ricci WM, Binder EF, Rodebaugh TL, Wendleton L, Doré P, Lenze EJ.

PLoS One. 2015 Mar 17;10(3):e0120685. doi: 10.1371/journal.pone.0120685. eCollection 2015. Erratum in: PLoS One. 2015;10(4):e0126451.

10.

Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity.

Verhagen M, van der Meij A, van Deurzen PA, Janzing JG, Arias-Vásquez A, Buitelaar JK, Franke B.

Mol Psychiatry. 2010 Mar;15(3):260-71. doi: 10.1038/mp.2008.109. Epub 2008 Oct 14.

PMID:
18852698
11.

Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients.

Zou YF, Wang Y, Liu P, Feng XL, Wang BY, Zang TH, Yu X, Wei J, Liu ZC, Liu Y, Tao M, Li HC, Li KQ, Hu J, Li M, Zhang KR, Ye DQ, Xu XP.

Neuropsychobiology. 2010;61(2):71-8. doi: 10.1159/000265132. Epub 2009 Dec 12.

PMID:
20016225
12.

Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine.

Zou YF, Wang Y, Liu P, Feng XL, Wang BY, Zang TH, Yu X, Wei J, Liu ZC, Liu Y, Tao M, Li HC, Li KQ, Hu J, Li M, Zhang KR, Ye DQ, Xu XP.

Hum Psychopharmacol. 2010 Mar;25(2):145-52. doi: 10.1002/hup.1099.

PMID:
20196181
13.

Association between C-281A and val66met functional polymorphisms of BDNF gene and risk of recurrent major depressive disorder in Polish population.

Suchanek R, Owczarek A, Kowalczyk M, Kucia K, Kowalski J.

J Mol Neurosci. 2011 Mar;43(3):524-30. doi: 10.1007/s12031-010-9478-y. Epub 2010 Nov 20.

PMID:
21103954
14.

Cerebral 5-HT2A receptor and serotonin transporter binding in humans are not affected by the val66met BDNF polymorphism status or blood BDNF levels.

Klein AB, Trajkovska V, Erritzoe D, Haugbol S, Madsen J, Baaré W, Aznar S, Knudsen GM.

J Cereb Blood Flow Metab. 2010 Nov;30(11):e1-7. doi: 10.1038/jcbfm.2010.114. Epub 2010 Aug 25.

15.

Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.

Choi MJ, Kang RH, Lim SW, Oh KS, Lee MS.

Brain Res. 2006 Nov 6;1118(1):176-82. Epub 2006 Sep 18.

PMID:
16979146
17.

Brain-derived neurotrophic factor Val66Met polymorphism and 6-month antidepressant remission in depressed Caucasian patients.

Colle R, Gressier F, Verstuyft C, Deflesselle E, Lépine JP, Ferreri F, Hardy P, Guilloux JP, Petit AC, Fève B, Falissard B, Becquemont L, Corruble E.

J Affect Disord. 2015 Apr 1;175:233-40. doi: 10.1016/j.jad.2015.01.013. Epub 2015 Jan 21.

PMID:
25658497
18.

Genetic epistasis between the brain-derived neurotrophic factor Val66Met polymorphism and the 5-HTT promoter polymorphism moderates the susceptibility to depressive disorders after childhood abuse.

Grabe HJ, Schwahn C, Mahler J, Appel K, Schulz A, Spitzer C, Fenske K, Barnow S, Freyberger HJ, Teumer A, Petersmann A, Biffar R, Rosskopf D, John U, Völzke H.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30;36(2):264-70. doi: 10.1016/j.pnpbp.2011.09.010. Epub 2011 Oct 2.

PMID:
21996278
19.

BDNF Val66met and 5-HTTLPR polymorphisms predict a human in vivo marker for brain serotonin levels.

Fisher PM, Holst KK, Adamsen D, Klein AB, Frokjaer VG, Jensen PS, Svarer C, Gillings N, Baare WF, Mikkelsen JD, Knudsen GM.

Hum Brain Mapp. 2015 Jan;36(1):313-23. doi: 10.1002/hbm.22630. Epub 2014 Sep 13.

PMID:
25220079
20.

Imaging the serotonin 1A receptor using [11C]WAY100635 in healthy controls and major depression.

Hesselgrave N, Parsey RV.

Philos Trans R Soc Lond B Biol Sci. 2013 Feb 25;368(1615):20120004. doi: 10.1098/rstb.2012.0004. Print 2013. Review.

Supplemental Content

Support Center